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Chondrocytes
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Nutramax Laboratories Inc, Edgewood, MD 21040, USA
Avocado/soy unsaponifiable (ASU) components are reported to have a chondroprotective effect
by virtue of anti-inflammatory and proanabolic effects on articular chondrocytes. The identity
of the active component(s) remains unknown. In general, sterols, the major component of
unsaponifiable plant material have been demonstrated to be anti-inflammatory in vitro and
in animal models. These studies were designed to clarify whether the sterol content of ASU
preparations were the primary contributors to biological activity in articular chondrocytes.
ASU samples were analyzed by high pressure liquid chromatography (HPLC) and GC mass
spectrometry. The sterol content was normalized between diverse samples prior to in vitro
testing on bovine chondrocytes. Anabolic activity was monitored by uptake of 35-sulfate into
proteoglycans and quantitation of labeled hydroxyproline and proline content after incubation
with labeled proline. Anti-inflammatory activity was assayed by measuring reduction of
interleukin-1 (IL-1)-induced synthesis of PGE2 and metalloproteases and release of label from
tissue prelabeled with S-35.All ASU samples exerted a similar time-dependent up-regulation
of 35-sulfate uptake in bovine cells reaching a maximum of greater than 100% after 72h at
sterol doses of 1–10mg/ml. Non-collagenous protein (NCP) and collagen synthesis were
similarly up-regulated. All ASU were equally effective in dose dependently inhibiting
IL-1-induced MMP-3 activity (23–37%), labeled sulfate release (15–23%) and PGE2 synthesis
(45–58%). Up-regulation of glycosaminoglycan and collagen synthesis and reduction of IL-1
effects in cartilage are consistent with chondroprotective activity. The similarity of activity
of ASU from diverse sources when tested at equal sterol levels suggests sterols are important
for biologic effects in articular chondrocytes.
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Introduction
There is a great deal of interest in the use of botanical
material in osteoarthritic and rheumatoid arthritic
disorders (1). For example, bromelain, an extract from
the pineapple plant, demonstrates anti-inflammatory
and analgesic properties in clinical osteoarthritis trials
(2). Anti-inflammatory activity is also present in the
sesquiterpenes from turmeric species (3) and avocado
and soybean oils contain a class of biologically active
compounds classified as unsaponifiable lipids [avocado/
soy unsaponifiables (ASU)] (4). The major components
of ASU by weight are the phytosterols beta-sitosterol,
campesterol and stigmasterol.
Early studies indicate the primary beneficial action
of phytosterols was their ability to inhibit cholesterol
absorption and interfere with endogenous cholesterol
biosynthesis (5). Phytosterols in general, and beta-
sitosterol in particular, are now considered potent anti-
inflammatory agents with antioxidant and analgesic
activity (6–8). Sterol extracts from different plant sources
indicate their widespread distribution, and animal tests
show their anti-inflammatory potency (9, 10).
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properly cited.ASU has also been recommended for treating arthritis
with published clinical trials in animals and humans
(10–13). For example, oral administration of ASU to
meniscectomized sheep for 3–6 months elicited a protec-
tive effect on articular cartilage (12). The authors
suggested ASU may be considered a symptomatic
disease-modifying osteoarthritic compound.
ASUs stimulate aggrecan synthesis while inhibiting
stromelysin activity in osteoarthritic chondrocytes (14).
The in vitro cartilage model generally used to test ASU
is based on monitoring reduction of interleukin-1
(IL-1)-induced metalloprotease activity, nitric oxide or
eicosanoid synthesis (all agents promoting cartilage
degradation and tissue inflammation) (15). The validity
of the model generally is accepted, as elevated levels of
IL-1 are believed to be involved in initiating cartilage
degradation (16). In vitro testing of ASU on articular
cartilage showed a 2:1 soy/avocado combination was
more effective than the unsaponifiable fraction of
avocado or soy used separately (17). Fibroblasts also
appear responsive to ASU as the metalloproteases
MMP-2 and MMP-3 are inhibited at low doses, while
the tissue inhibitors of metalloproteases are increased at
higher doses (14). Other indices tested relate to a possible
increased capacity for repair and regeneration of articular
cartilage. For example, the anticatabolic activity of
ASU is paired with a direct effect of ASU on stimulating
collagen and proteoglycan production, possibly by
increasing transforming growth factor beta synthesis
(18). ASU is generally a complex mixture of many
compounds including fat-soluble vitamins, sterols, triter-
pene alcohols and possibly furan fatty acids. Therefore,
the identity of the active agent(s) remains uncertain.
The objectives of this investigation were (i) to identify
the sterol composition of unsaponifiable material in
ASU from diverse sources; (ii) test the influence these
materials have on up-regulation of glycosaminoglycan
and collagen synthesis of bovine chondrocytes in vitro
and (iii) similarly test this material for anticatabolic/
anti-inflammatory activity in an IL-1-induced in vitro
model of articular cartilage breakdown. Prior to testing,
all ASU material was normalized to identical sterol
content. This approach allowed testing of the hypothesis
that the biological activities of ASU from diverse sources
are comparable and may be dependent on sterol content.
Methods
Assays of anabolic and anticatabolic activity in chon-
drocytes exposed to various 2:1 soy/avocado ASU
formulations. We standardized the sterol content of
each sample before testing and in some studies, compared
the data with that for purified beta-sitosterol. Before
testing, the compositional profile of each preparation
was analyzed by high pressure liquid chromatography
(HPLC) (19) and gas chromatography (GC) mass
spectrometry.
We tested 2:1 formulations of soy/avocado ASU
obtained from several sources. Formula 1 was NMX-
1000
TM obtained from Nutramax Laboratories
(Edgewood, MD). Formula 2 consisted of two-part soy
unsaponifiables (Cargill, Minneapolis, MN) and one-part
avocado unsaponifiables (Croda, Yorkshire, England).
Additional materials tested include a commercially avail-
able researched preparation (Laboratories Pharmascience,
Courbevoie, France) and a sample of beta-sitosterol
(95% pure; Sigma-Aldrich, St Louis, MO). All samples
were used after 100% ethanol extraction/dissolution of
the product using continuous shaking at 50C for 60min
and dilution to a final sterol concentration of 10mg/ml.
Chromatographic Procedures
HPLC separation was achieved by applying 600mg total
weight of material onto a Luna C-18, 2504.6mm, 5mm
reverse-phase column (Phenomenex, Torrance, CA) with
samples at 40C and the column at room temperature.
The flow rate was 1ml/min with acetonitrile/methanol
(50:50, v/v) containing 3% water as the mobile phase.
Peaks were monitored at 210nm and ASU components
were identified by comparison with authentic standards
when possible. The concentrations of the components
stigmasterol, beta-sitosterol and campesterol were deter-
mined by calculating peak area ratios against an internal
standard with known concentrations of the analytes.
GC analysis was performed on an Agilent 6890 System
(Palo Alto, CA) equipped with a split/splitless injector
port and a flame ionization detector. The separation
of phytosterols was accomplished on a Restek XTI-5
column (30m0.32mm0.25mm) with the injector and
detector temperatures maintained at 330C; column
temperature program was started at 250C and increased
to 330C at a rate of 10/min and held at 330C for
5min. We injected 1ml with a split ratio of 15:1. Positive
identification of the analytes was confirmed by mass
spectroscopy and comparison of retention times with
authentic samples.
In vitro Culture Studies
For in vitro metabolic synthesis studies, articular chon-
drocytes obtained by collagenase digestion of the
metacarpal joint of retired, aged Holstein cows (viability
by trypan blue 95%) were plated into 48 well multi-
cultured plates at 100000cells/well and incubated in
DMEM/F-12 (Cambrex, East Rutherford, NJ.) plus
10% fetal calf serum, 50mg/ml ascorbic acid, penicillin
G (100000U/l), streptomycin (100000mg/l) and ampho-
tericin B (250mg/l) for 7–10 days to acclimate the cells.
Since chondrocyte synthetic activity is influenced by the
glucose content of the medium and normal culture
192 Metabolic Effects of Avocado/Soy Unsaponifiablesmedium glucose can be as high as 17mmol/l, we
formulated DMEM/F-12 medium to contain 5mmol/l
glucose to mimic in vivo serum concentrations (20).
The rationale for this was the low synovial fluid glucose
levels in a canine model of osteoarthritis (21) and the
association with inflammatory joint disease (22). To more
closely mimic in vivo conditions, all cell cultures subse-
quently were acclimated for 24h to a modified DMEM/
F-12 medium containing physiologic levels of glucose
(5mmol/l) plus 1% fetal calf serum. All testing was
performed in this same medium. For comparison
purposes, all ASU preparations were diluted to yield
identical sterol concentrations (each containing <0.1%
ethanol). Cultures were exposed for 24 or 72h to the
various unsaponifiable preparations at doses of 0.1–10
and 0.1–25mg/ml, respectively, based on sterol content.
Radiolabeled sulfate at 5mCi/ml was added during the
terminal 6h of incubation. For the long-term exposure
study and for the collagen analysis, we tested only
the commercial preparation and Formula 1. To assess
the long-term effects, replicate cultures were similarly
exposed to ASU for 10 days with media changes every 2
days. Increases in GAG (glycosaminoglycan) synthetic
activity was determined by assaying GAG using 1,9-
Dimethylmethylene blue reagent (23) and monitoring
CPM 35-sulfate uptake/culture. No attempt was made to
characterize the distribution of label into the various
classes of proteoglycans and the data was analyzed with
one way analysis of variance (ANOVA).
Collagen Synthesis
We analyzed collagen synthesis by comparing the effect
of the commercial ASU and Formula 1 ASU normalized
to contain equal sterol levels. Collagenase-sensitive
material was assayed according using the method of
Diegelmann et al. (24). Briefly, chondrocytes cultured in
a 24 well plate at a density of 200000cells/well with
DMEM-F-12 containing 5mmol/l glucose and 1% fetal
calf serum were exposed to 1, 5 and 10mg/ml of each
preparation for 72h. Media were changed daily and
5mCi/ml tritiated proline was added for the last 24h.
Cultures were terminated by addition of concentrated
trichloroacetic acid (TCA) to 10% at 5C. The precipitate
was repeatedly washed with 10% TCA with a last rinse
of a 1:1 solution of diethylether and methanol. Collagen
in TCA-precipitated, air-dried plates was digested by
adding an incubation cocktail containing 25mg purified
collagenase (CLSPA; Worthington Biochemical Corp,
Lakewood, NJ) in 200ml 0.05mol/l Tris (pH 7.6) and
0.005mol/l CaCl2. The plates were incubated for 3–6h at
37C. Radioactivity in the supernatant (collagen fraction)
and TCA-precipitated pellet (NCP) were counted in
multiplate wells after adding 300ml scintillant (Hewlett-
Packard, Houston, TX) to 100ml sample.
Anticatabolic Studies
All ASU preparations were tested for anticatabolic
activity at sterol doses of 10, 5, 1 and 0.1mg/ml.
Chondrocytes plated into 48 well multicultured plates
(100000cells/well) were prelabeled with 35-sulfate
for 72h in DMEM/F-12 plus 10% fetal calf serum.
Unincorporated label was washed out by preincubation
for 24h while the cells were acclimated to DMEM/F-12
containing 1% fetal calf serum and 5mmol/l glucose
before adding the agents. All agents were added in a total
volume of 0.5ml and released activity monitored after
24h. Additionally, 100ml aliquots of media were removed
for analysis of general metalloprotease activity using the
OmniMMP
TM
fluorescence substrate (Mca-PLGDpaAR)
(Biomol International, Plymouth Meeting, PA). Total
enzyme activity was assayed after activating latent
enzymes with trypsin and reading the reaction in 96
well culture wells in kinetic mode on a Molecular Devices
Spectra Max Fluorescence reader (Sunnyvale, CA).
In effect, the sulfate release assay was a measure of
active enzyme activity, while the fluorescence MMP assay
reflected the total enzyme content.
Anti-inflammatory Assays
Six millimeter diameter bovine cartilage explants from
normal metacarpal joints of young steers (15months)
were conditioned to a metabolic steady state in DMEM/
F-12–10% fetal bovine serum and penicillin/streptomycin
for 6–10 days before use. Cartilage explants were
transferred to a 48 well culture plate with two explants
per well. Each well contained 1ml of DMEM-F12+10%
fetal bovine serum with penicillin/streptomycin and
0, 0.001, 0.01, 0.1 and 1mg/ml of Formula 1 or the
commercially available ASU for 72h before adding
5ng/ml of recombinant human IL-1 beta (R&D
Systems, Minneapolis, MN) and monitoring prostaglan-
din E2 (PGE2) levels after 24h. The PGE2 levels from the
media samples were analyzed using the R&D Systems
PGE2 kit. We performed all experiments in duplicate
using different animals. An estimation of the toxic effect
of a 5-day exposure of chondrocytes to ASU also was
assessed using Molecular Bioprobes Fluorescent Live/
Dead Cell Kit (Invitrogen, Chicago, IL).
We calculated the mean and standard error of the mean
for each sample group. For the isotopic uptake studies
and collagen analysis, means were compared using the
unpaired Student’s t-test. For assays of GAG-specific
activity, one-way analysis of variance (ANOVA) and
the student Newman-Keul’s multiple comparison test
for significance was used. Statistical significance was
accepted at P<0.05. All experiments were performed
in triplicate and representative data included in the
manuscript.
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Chromatographic Analysis
Slightly varying levels of the three primary sterols were
present in all preparations (Fig. 1) with the commercial
preparation containing three additional major unidenti-
fied peaks (Fig. 1A). Based on area, Formulas 1 and 2
ASU had similar HPLC profiles (Fig. 1B and C,
respectively), but only 1.5% of the total chromatographic
area corresponded to the three unknown peaks compared
to the 80% seen in the commercial preparation.
Gas chromatographic analysis revealed the total sterol
content of the commercial preparation, Formula 1, and
components of Formula 2 were 34%, 30%, 60% (soy)
and 70.8% (avocado) by weight, respectively (Fig. 2).
Mass spectra data confirmed the sterol identity in all
samples and additionally identified several major and
some minor components of each sample (Table 1).
Metabolic Analysis
Short-term Exposure
Twenty-four hour exposure of chondrocytes to ASU
resulted in a stimulation (P=0.05) at all doses tested
(Fig. 3) with no pronounced dose response or any
difference between the different ASU preparations.
In the one instance where tested, beta-sitosterol activity
was slightly less than the other preparations. However,
exposure to ASU for 72h showed a trend toward an
increase (P<0.01) in positive dose response (Fig. 4).
There was little difference between preparations except at
greater than 6.25mg/ml sterol doses where the increase in
synthetic activity varied slightly between samples.
Long-term Exposure
Insulin-like growth factor (IGF-1) was used as a positive
control since it exerts a stimulatory effect on chondro-
cytes (25). Continuous exposure of cells to 50ng/ml
(IGF-1) or 1mg/ml Formula 1 for 10 days had a chronic
stimulatory effect on glycosaminoglycan synthesis.
When measured as CPM 35-sulfate/culture, the level of
synthesis of GAG over the time of exposure to isotope,
increases of 233% (22%) and 148% (32%) (P<0.05)
for IGF-1 and Formula 1, respectively were seen
compared to controls (data not graphed).
Collagen Synthesis
All ASU agents’ up-regulated collagen and NCP synth-
esis with a dose-dependent stimulation apparent between
doses of 1 and 10mg/ml (Fig. 5). The effect on NCP
synthesis was greater than (P<0.05) collagen synthesis
by at least 2-fold. At 10mg/ml, the commercial ASU
stimulated NCP by 58% and collagen by 30% (P<0.05).
NCP and collagen synthesis were equally up-regulated by
82% with 10mg/ml Formula 1 ASU (P<0.01) (Fig. 3).
Anti-inflammatory Activity
Assays of anti-inflammatory/anticatabolic activity
including a fluorogenic assay of MMP levels (after
trypsin activation) varied although there was a little
evidence of a dose-dependent response with any prepara-
tion at the doses tested. The commercial preparation and
Formula 1 had a maximum inhibition of IL-1-induced
MMP of 35–37% associated with a dose of 10mg/ml
and a 18–39% reduction at 0.1mg/ml, the lowest dose
tested. In contrast, Formula 2 was one-third as active
(Table 2). The MMP assay may reflect total enzyme
content after IL-1 exposure (depending on whether
Figure 1. (A) The HPLC chromatogram of the commercial preparation
is characterized by the presence of multiple unidentified peaks not
present in the other preparations. GC mass spectrophotometry analysis
was suggestive only of long-chain hydrocarbons. (B) The chromatogram
of Formula 1 shows predominantly known sterols. (C) The chromato-
gram of Formula 2 also shows predominantly known sterols with trace
amounts of unidentified compounds corresponding to the commercial
preparation.
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Figure 2. Gas chromatograph of major sterol components of tested
samples. Asterisk indicates values supplied by manufacturer.
194 Metabolic Effects of Avocado/Soy UnsaponifiablesIL-1-treated cultures release aggrecan fragments as well
as intact molecules). The release of 35-sulfate from
prelabeled cultures more accurately reflected enzyme
activity. There was no dose response, but all three
preparations of ASU-inhibited sulfate release at doses
of 1–10mg/ml, but not at 0.1mg/ml. At the time period
tested, (24h) prostaglandin E2 synthesis, elevated by
860% after IL-1 exposure, was inhibited by 45 to 54%
with the commercial ASU and Formula 1 ASU at doses
of 0.01, 0.1 and 1mg/ml, but not at 0.001mg/ml,
the lowest dose tested. Formula 2 was not tested.
There was no apparent dose response in this assay.
Table 1. Positive mass spectra identification of unsaponifiable lipid preparations
Components Commercial preparation Formula 1 Formula 2 (soy unsaponifiables) Formula 2 (avocado
unsaponifiables)
Major components
C20H30O2 (?) Sitosterol Sitosterol Sitosterol
C20H28O2 (?) Stigmasterol Stigmasterol Stigmasterol
Sitosterol Campesterol Campesterol Campesterol
Stigmasterol Nonacosane
Campesterol Ergost-5-en-3-ol
Squalene
Beta tocopherol
Des-methyl tocopherol
Minor components
Oleic Acid Ergostenol Oleic acid na
Docosane Hexadecanoic Acid Stigmast-4-en-3-one
Alpha Amyrin Heptacosane
Cholesterol Nonacosane
Tocopherol
Stigmast-7-en-3-ol
na, analysis not performed.
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Figure 5. Graph demonstrating the dose-dependent effect of ASU
preparations (mg/ml sterol) on collagen and NCP synthesis by bovine
chondrocytes. Data are plotted as percent change from controlSEM.
CP, commercial product; F, Formula 1. All values are significantly
different from control at P<0.05 with CP effect on NCP 2-fold greater
than CP effect on collagen (P<0.05).
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Figure 4. Up-regulation of 35-sulfate incorporation in bovine chondro-
cytes exposed to ASU for 72h. Data are plotted as the percent change
from controlSEM. All values are statistically different from control
at P<0.05.
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Figure 3. Comparison of 35-sulfate incorporation into glycosaminogly-
cans of bovine chondrocytes exposed to various ASU preparations for
24h under conditions of equal sterol content. Values given as mean
CPM (standard deviation). Arrows indicate doses which differed
significantly from control at P<0.05 or better.
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cells to 1 or 10mg/ml with any ASU preparation.
Discussion
Three different ASU preparations equalized to contain
equivalent sterol content had similar metabolic effects on
articular chondrocytes. Chondrocyte response was mon-
itored in vitro under conditions of physiologic glucose
levels to define the role of ASU as an asymptomatic
disease-modifying osteoarthritic agent. There are limita-
tions of our study with regard to interpreting the effects
of ASU on osteoarthritic joints. One is the lack of
definitive identification of the various minor components
of ASU. Although sterols constitute a major fraction
of ASU, other components including alpha- and beta-
amyrin also are considered to have anti-inflammatory
and possible anabolic effects on tissue metabolism (9,26).
We did not assay for these components and although our
data suggest sterols as the major component with biologic
activity, the difference between preparations with regard
to MMP content suggest these other agents may also be
active. When beta-sitosterol was tested at similar doses,
slightly lesser activity was noted, suggesting perhaps
an interaction between the various ASU components
that promotes greater responses. The available clinical
evidence suggests symptomatic relief in patients with
osteoarthritis which relates more to ASU’s anti-
inflammatory activity rather than the up-regulation of
cartilage matrix synthesis (11).
Our results mimic those of a previously published
report on ASU (15). However, our doses are expressed as
mg/ml sterol rather than total weight ASU. In that report,
Henrotin et al. (15). used doses of ASU by weight,
ranging from 0.1 to 40mg/ml, with greater activity seen at
the higher concentrations. Considering their preparation
contained approximately 34% sterol content (based on
our analysis of the commercial product), the actual doses
of sterol were 0.03–13.3mg/ml, which was within the
range of our tests. Also, their data applied to cells
cultured in an alginate system and measurement of
accumulated matrix for a 12-day exposure period.
Our data on short-term 24h exposure did not show a
pronounced dose response, but longer-term exposure of
72h showed a positive direct-dose response with max-
imum activity at 25mg/ml sterol (75mg/ml ASU), the
highest dose tested. Our extended 10-day exposure also
resulted in a significant increase of glycosaminoglycan
synthesis.
Our findings suggest a relationship between ASU
content and biologic activity at 0.1–25mg/ml sterol
levels, with some variation in chondrocyte synthetic
response depending on time of exposure. Regarding
anti-inflammatory indices, we observed maximum inhibi-
tion of prostaglandin synthesis, metalloprotease activity
and release of radiolabeled sulfate from prelabeled
cartilage, at all the intermediate doses tested.
An important question is whether the major peaks
in the commercial ASU preparation, which were almost
absent in the other preparations, contributed to ASU
biologic activity. Based on our experimental design,
where all preparations were tested after equalization
to contain identical sterol content, we observed no
additional effects that could be attributed to other
components.
Evaluation of collagen synthesis suggests greater
stimulation at the higher doses. Similar results were
found by Mauviel et al. (27) and Werman et al. (28)
However, variation was seen between commercial pro-
duct and Formula 1 preparations in the degree
Table 2. Dose-dependent antiinflammatory/anticatabolic effects
of ASU on IL-1 treated chondrocytes: comparative analysis of ASU
preparations
Sample Dose
(mg/ml)
MMP
activity
% of Total
CPM 35-Sulfate
released 24h
after IL-1 exposure
24h PGE2
synthesis
Change
from
IL-1 (%)
Commercial preparation
Control 51.3 (3.6) 15% (4%) 104 (12)
IL-1 110.9 (5.1) 25% (8%)
b 999 (240)
10 72.1 (3.4)
a 14% (9%) na na
5 82.1 (3.2)
a 12% (9%) na na
1 86.7 (2.2)
a 16% (8%) 512 (76)
a 49
0.1 92.1 (4)
a 27% (8%)
b 547 (70)
a 45
0.01 – – 472 (49)
a 53
0.001 – – 849 (76) 15
Formula 1 (ASU)
Control 48 (1.4) 10% (3%) 104 (12)
IL-1 105.3 (5.4)
a 23% (9%)
b 999 (240)
10 66.3 (2.1)
a 7% (3%) na na
5 66.8 (2.1)
a 12% (7%) na na
1 70.8 (0.5)
a 14% (6%) 459 (67)
a 54
0.1 64.7 (3)
a 26% (9%)
b 507 (76)
a 50
0.01 – – 417 (26)
a 58
0.001 – – 725 (79) 37
Formula 2 (ASU)
Control 38.5 (2.5) 16% (5%) na
IL-1 98 (3) 30% (11%)
b na
10 88.2 (5.2) 14% (5%) na
5 88 (2)
a 16% (8%) na
1 82.7 (3.2)
a 15% (7%) na
0.1 85.5 (5.8) 26% (5%)
b na
Values are the meansSEM; ASU, avocado/soy unsaponifiables;
asignificant reduction of IL-1 induced increase in MMP or PGE2
expressed as pM/min/ml substrate conversion (n=4) and pg PGE2/
10mg tissue (n=8), respectively; SO4 release expressed as% of total
CPM incorporated released over 24h (n=8);
bvalues significantly
different from control (minus IL-1) cultures; na, not analyzed.
196 Metabolic Effects of Avocado/Soy Unsaponifiablesof stimulation. A 3- to 5-fold greater dose-dependent
stimulation occurred in collagen and NCP synthesis with
Formula 1. The reason for these differences nor the
significance is not known, as both preparations contained
equal sterol concentrations.
Several mechanisms could influence chondrocyte
metabolism. For example, ASU enhances synthesis of
transforming growth factor beta (18), inhibits metallo-
protease activity and eicosanoid synthesis (17). Sterols are
also rapidly incorporated into cells causing an increase
in cellular antioxidant status (29). Sterols also inhibit
synthesis and release of PGE2, a potent proinflammatory
eicosanoid (30). previously shown to have an inhibitory
effect on cartilage metabolism (31). Whatever the
mechanism, there is substantial evidence that ASU
containing sterols are anti-inflammatory and provide
protection against cartilage degeneration.
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